13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q3 2024 · Filed November 12, 2024 · Accession 0000902664-24-006434
Total Value
$91.0M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 6,164,548 | $50.5M | 55.55% |
| 2 | INVIVYD INC | IVVD | 9,248,250 | $9.4M | 10.37% |
| 3 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $7.1M | 7.83% |
| 4 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $4.7M | 5.16% |
| 5 | TG THERAPEUTICS INC | TGTX | 161,600 | $3.8M | 4.15% |
| 6 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 110,400 | $3.5M | 3.89% |
| 7 | SILENCE THERAPEUTICS PLC | SLNCF | 185,100 | $3.4M | 3.70% |
| 8 | BRIDGEBIO PHARMA INC | BBIO | 121,200 | $3.1M | 3.39% |
| 9 | CURIS INC | CRIS | 421,951 | $2.3M | 2.50% |
| 10 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $1.9M | 2.04% |
| 11 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $1.3M | 1.43% |